Hopes for access to the drug were immediately dashed by cost-effectiveness watchdog NICE – the ultimate arbiter ... drug only in people who have either no copies or just one copy of the ApoE4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback